Cargando...
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
BACKGROUND: The manufacturing process of a new intravenous immune globulin (IVIG) 10% liquid product incorporates two dedicated pathogen safety steps: solvent/detergent (S/D) treatment and nanofiltration (20 nm). Ion-exchange chromatography (IEC) during protein purification also contributes to patho...
Guardado en:
| Publicado en: | BioDrugs |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5380692/ https://ncbi.nlm.nih.gov/pubmed/28236170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-017-0212-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|